TELETRADER News
9/1/2020, 9:32 AM (Source: TeleTrader)
more TeleTrader news

Sanofi+1.09%

86.37
Chart for: SANOFI

Sanofi stops trial of potential COVID treatment

Pharmaceutical company Sanofi SA revealed on Tuesday that it is halting its Phase 3 trial of rheumatoid arthritis drug Kevzara as a potential treatment for COVID-19. The trials started in March and were conducted in 11 countries.

The medicine showed trends "toward a decrease in duration of hospital stay as well as an acceleration in time to improve clinical outcomes," the report stated, although these results were not statistically significant. Serious adverse side effects were experienced by 26-29% of Kevzara patients and 24% of placebo patients, including severe infections and events leading to death.

Breaking the News / DJ